Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
5.01
Dollar change
+0.01
Percentage change
0.20
%
Index- P/E- EPS (ttm)-1.53 Insider Own18.17% Shs Outstand42.42M Perf Week15.44%
Market Cap243.74M Forward P/E- EPS next Y-0.89 Insider Trans0.00% Shs Float39.81M Perf Month35.04%
Income-45.70M PEG- EPS next Q-0.20 Inst Own66.17% Short Float11.62% Perf Quarter1012.59%
Sales0.00M P/S- EPS this Y36.27% Inst Trans-2.99% Short Ratio1.50 Perf Half Y626.19%
Book/sh1.29 P/B3.88 EPS next Y-3.98% ROA-49.88% Short Interest4.63M Perf Year151.76%
Cash/sh1.71 P/C2.93 EPS next 5Y- ROE-88.03% 52W Range0.36 - 5.89 Perf YTD832.96%
Dividend Est.- P/FCF- EPS past 5Y-52.56% ROI-53.80% 52W High-14.94% Beta1.35
Dividend TTM- Quick Ratio21.22 Sales past 5Y0.00% Gross Margin- 52W Low1280.17% ATR (14)0.45
Dividend Ex-Date- Current Ratio21.22 EPS Y/Y TTM62.65% Oper. Margin0.00% RSI (14)70.08 Volatility9.66% 12.53%
Employees29 Debt/Eq0.55 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.75
Option/ShortYes / Yes LT Debt/Eq0.55 EPS Q/Q77.21% Payout- Rel Volume0.42 Prev Close5.00
Sales Surprise- EPS Surprise18.10% Sales Q/Q- EarningsMar 06 BMO Avg Volume3.08M Price5.01
SMA2012.37% SMA5044.05% SMA200225.80% Trades Volume1,287,338 Change0.20%
Date Action Analyst Rating Change Price Target Change
Mar-01-24Initiated JMP Securities Mkt Outperform $7
May-30-23Upgrade SVB Securities Market Perform → Outperform $5 → $8
Dec-23-21Initiated H.C. Wainwright Buy $12
Mar-07-24 01:54PM
Mar-06-24 02:51PM
07:30AM
Mar-05-24 06:00PM
04:50PM
07:30AM Loading…
Mar-04-24 07:30AM
Feb-28-24 07:30AM
Feb-23-24 09:17AM
Feb-22-24 07:30AM
Jan-22-24 07:30AM
Jan-09-24 10:25AM
Jan-05-24 07:30AM
Nov-22-23 07:30AM
Nov-02-23 09:40AM
07:30AM
07:30AM Loading…
Sep-05-23 07:30AM
Aug-16-23 07:30AM
Aug-03-23 07:30AM
Jul-13-23 08:00AM
Jun-08-23 10:41PM
04:01PM
Jun-03-23 09:00AM
May-19-23 06:54AM
May-15-23 07:30AM
Apr-26-23 04:05PM
Apr-17-23 10:15AM
Mar-23-23 09:40AM
Mar-14-23 04:30PM
Mar-09-23 07:30AM
Mar-01-23 07:00AM
07:00AM Loading…
Feb-08-23 07:00AM
Jan-09-23 07:30AM
Jan-06-23 08:15AM
Nov-30-22 07:30AM
Nov-03-22 07:30AM
Aug-12-22 09:30AM
Aug-04-22 07:30AM
Aug-03-22 08:00AM
Jul-28-22 08:50AM
08:45AM
Jul-14-22 08:45AM
Jun-01-22 07:30AM
May-26-22 05:05PM
08:27AM
May-25-22 07:30AM
May-05-22 07:30AM
Apr-27-22 10:05AM
Mar-24-22 01:12PM
Mar-14-22 07:00AM
Mar-03-22 07:30AM
Mar-01-22 07:00AM
Jan-10-22 07:00AM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Dec-16-21 09:14AM
Nov-18-21 08:00AM
Nov-12-21 07:30AM
Oct-20-21 07:00AM
Oct-14-21 07:00AM
Sep-25-21 09:52AM
Sep-07-21 07:00AM
Aug-12-21 04:05PM
Aug-04-21 07:00AM
Jun-24-21 08:44PM
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm's program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.